Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research.

Lifetime Achievement Awardee

Katalin Karikó, PhD

Senior VP, BioNTech


Karen Akinsanya, PhD

Chief Biomedical Scientist

Patrizia Cavazzoni, MD

Director, Center for Drug Evaluation and Research

Gary Gibbons, MD

Director, NHLBI

Aida Habtezion, MD

CMO, Pfizer

Dean Li, MD, PhD

Executive VP and President of Merck Research Laboratories

Michelle McMurry-Heath, MD, PhD

President & CEO, Biotechnology Innovation Organization

Merdad Parsey, MD, PhD

CMO, Gilead

Alfred Sandrock, MD, PhD

Former Head of R&D

Daniel Skovronsky, MD, PhD

President, Lilly Research Laboratories
Chief Scientific & Medical Officer, Eli Lilly and Company

Claude Bertrand, PhD

Executive Vice President, Chief Scientific Officer, R&D

Lisa Coussens, PhD

Associate Director for Basic Research, Knight Cancer Institute, OHSU; and President, AACR

Christopher Gibson, PhD

Co-Founder, CEO of Recursion

Joe Jimenez, MBA

Co-Founder and Managing Director
Aditum Bio

Mathai Mammen, MD, PhD

Global Head, R&D, Janssen Pharmaceutical Companies of Johnson & Johnson

Maria Millan, MD

President and CEO, CIRM

Aviv Regev, PhD

Executive VP, Research and Early Development

Randy Schekman, PhD

Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate

Marc Tessier-Lavigne, PhD

President and Bing Presidential Professor
Stanford University

James (Jay) Bradner, MD

Novartis Institutes for BioMedical Research

Ray Deshaies, PhD

Sr. Vice President, Global Research

David Goel

Founder & Managing General Partner, Matrix Capital Management

Daphne Koller, PhD

Founder & CEO, Insitro

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration

Vern Norviel, JD

Partner, Patents and Innovations
Wilson Sonsini

Madhuri Roy, PhD, JD


Michael E. Severino, MD

Vice Chairman and President



Amanda Chase, PhD

Associate Director of Strategic Research Development
Stanford Cardiovascular Institute

Joseph Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine

Sanjay Malhotra, PhD

Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
Oregon Health & Science University

Mark Mercola, PhD

Professor of Medicine
Stanford University School of Medicine

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Support by

in alphabetical order

For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.